Skip to main content

Advertisement

SpringerLink
Log in

Intranasal oxytocin and NSAIDs

Comment on: Oxytocin nasal spray in fibromyalgic patients (Rheumatol Int. 2014 Aug;34(8):1047-52.)

  • Letter to the Editor - Food for Thought
  • Published:
Rheumatology International Aims and scope Submit manuscript

A Letter to the Editor - Critique and Appraisal to this article was published on 15 January 2015

The Original Article was published on 08 February 2014

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mameli S, Pisanu GM, Sardo S, Marchi A, Pili A, Carboni M, Minerba L, Trincas G, Carta MG, Melis MR, Agabio R (2014) Oxytocin nasal spray in fibromyalgic patients. Rheumatol Int 34:1047–1052

    Article  CAS  PubMed  Google Scholar 

  2. Anderberg UM, Uvnas-Moberg K (2000) Plasma oxytocin levels in female fibromyalgia syndrome patients. Z Rheumatol 59:373–379

    Article  CAS  PubMed  Google Scholar 

  3. Salonia A, Nappi RE, Pontillo M, Daverio R, Smeraldi A, Briganti A, Fabbri F, Zanni G, Rigatti P, Montorsi F (2005) Menstrual cycle-related changes in plasma oxytocin are relevant to normal sexual function in healthy women. Horm Behav 47:164–169

    Article  CAS  PubMed  Google Scholar 

  4. Pamuk ON, Cakir N (2005) The variation in chronic widespread pain and other symptoms in fibromyalgia patients. The effects of menses and menopause. Clin Exp Rheumatol 23:778–782

    CAS  PubMed  Google Scholar 

  5. Yeomans DC, Angst M, Mechanic J, Jacobs D Therapeutic effect of nasal oxytocin in chronic migraine: dependence on cytokines. In: International Headache Congress 2013, Boston: Cephalalgia 33 (8 Supplement): 58–59

  6. Guastella AJ, Hickie IB, McGuinness MM, Otis M, Woods EA, Disinger HM, Chan HK, Chen TF, Banati RB (2013) Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research. Psychoneuroendocrinology 38:612–625

    Article  CAS  PubMed  Google Scholar 

  7. Rash JA, Campbell TS (2014) Future directions for the investigation of intranasal oxytocin and pain: comment on: oxytocin nasal spray in fibromyalgic patients. Rheumatol Int 34:1177–1178

    Article  PubMed  Google Scholar 

  8. Agabio R, Mameli S, Sardo S, Minerba L, Melis MR (2014) Oxytocin nasal spray in fibromyalgic patients: additional information : reply to the comment to the editor entitled “Future directions for the investigation of intranasal oxytocin and pain”. Rheumatol Int 34:1335–1336

    Article  PubMed  Google Scholar 

  9. Rash JA, Aguirre-Camacho A, Campbell TS (2014) Oxytocin and pain: a systematic review and synthesis of findings. Clin J Pain 30:453–462

    PubMed  Google Scholar 

  10. Ohlsson B, Truedsson M, Bengtsson M, Torstenson R, Sjolund K, Bjornsson ES, Simren M (2005) Effects of long-term treatment with oxytocin in chronic constipation; a double blind, placebo-controlled pilot trial. Neurogastroenterol Motil 17:697–704

    Article  CAS  PubMed  Google Scholar 

  11. Rash JA, Campbell TS (2014) The effect of intranasal oxytocin administration on acute cold pressor pain: a placebo-controlled, double-blind, within-participants crossover investigation. Psychosom Med 76:422–429

    Article  CAS  PubMed  Google Scholar 

  12. Singer T, Snozzi R, Bird G, Petrovic P, Silani G, Heinrichs M, Dolan RJ (2008) Effects of oxytocin and prosocial behavior on brain responses to direct and vicariously experienced pain. Emotion 8:781–791

    Article  PubMed Central  PubMed  Google Scholar 

  13. Uryvaev IuV, Petrov GA (1996) Decreased pain sensitivity in man after treatment with superlow doses of oxytocin. Biull Eksp Biol Med 122:487–489

    Article  CAS  PubMed  Google Scholar 

  14. Wang YL, Yuan Y, Yang J, Wang CH, Pan YJ, Lu L, Wu YQ, Wang DX, Lv LX, Li RR, Xue L, Wang XH, Bi JW, Liu XF, Qian YN, Deng ZK, Zhang ZJ, Zhai XH, Zhou XJ, Wang GL, Zhai JX, Liu WY (2013) The interaction between the oxytocin and pain modulation in headache patients. Neuropeptides 47:93–97

    Article  CAS  PubMed  Google Scholar 

  15. Welch MG, Tamir H, Gross KJ, Chen J, Anwar M, Gershon MD (2009) Expression and developmental regulation of oxytocin (OT) and oxytocin receptors (OTR) in the enteric nervous system (ENS) and intestinal epithelium. J Comp Neurol 512:256–270

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Gossen A, Hahn A, Westphal L, Prinz S, Schultz RT, Grunder G, Spreckelmeyer KN (2012) Oxytocin plasma concentrations after single intranasal oxytocin administration—a study in healthy men. Neuropeptides 46:211–215

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. MGH/MIT/HMS Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massaschusetts General Hospital, Building 149, Thirteenth Street, Mail Code 149-2301, Charlestown, MA, 02129, USA

    Kenneth K. Kwong & Suk-tak Chan

Authors
  1. Kenneth K. Kwong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Suk-tak Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kenneth K. Kwong.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kwong, K.K., Chan, St. Intranasal oxytocin and NSAIDs. Rheumatol Int 35, 941–942 (2015). https://doi.org/10.1007/s00296-014-3163-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-014-3163-3

Keywords

Search

Navigation